ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Pulmicort® Dosieraerosol/- Respules/- Turbuhaler:AstraZeneca AG
Vollst. FachinformationDDDDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
Reg.InhaberStand d. Info. 
R03BA02 - BudesonideATC-DDD Version 2016. Source: WHO
R - Respiratory System

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.

R03 - Drugs for Obstructive Airway Diseases
 
R03B - Other Drugs for Obstructive Airway Diseases, Inhalants

This group comprises all drugs for obstructive airway diseases for inhalation excl. adrenergics (R03A).

See comment under R03A.

R03BA - Glucocorticoids

Combinations with adrenergics are classified in R03AK.
The combination of ciclosonide and tiotropium bromide is classified in R03BB54.
Fluticasone propionate is classified in R03BA05.

The DDDs are based on the starting dose in moderate to severe asthma.

R03BA02 - Budesonide
StärkeAdm.RouteNote
 Inhal.powder 
 Inhal.solution 
 Inhal.aerosol 
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home